Viewing Study NCT03670056


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-02-23 @ 8:07 PM
Study NCT ID: NCT03670056
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-20
First Post: 2018-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
Sponsor: Yale University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module